FNDC5 Antikörper (PE)
(1 reference)-
- Target Alle FNDC5 Antikörper anzeigen
- FNDC5 (Fibronectin Type III Domain Containing 5 (FNDC5))
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser FNDC5 Antikörper ist konjugiert mit PE
-
Applikation
- Western Blotting (WB)
- Kreuzreaktivität
- Human, Maus, Ratte
- Homologie
- Dog,Chicken,Rabbit
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human FNDC5 Irisin
- Isotyp
- IgG
- Top Product
- Discover our top product FNDC5 Primärantikörper
-
anti-Fibronectin Type III Domain Containing 5 (FNDC5) (AA 113-127) antibody
FNDC5 Reaktivität: Human IHC, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Fibronectin Type III Domain Containing 5 (FNDC5) (AA 77-144) antibodyFNDC5 Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Fibronectin Type III Domain Containing 5 (FNDC5) (AA 2-137) antibodyFNDC5 Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Fibronectin Type III Domain Containing 5 (FNDC5) (AA 81-143) antibodyFNDC5 Reaktivität: Human, Maus, Ratte WB, ELISA, ICC, IF (cc), IF (p), IHC (fro), IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Fibronectin Type III Domain Containing 5 (FNDC5) (AA 74-209) antibodyFNDC5 Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Fibronectin Type III Domain Containing 5 (FNDC5) (AA 12-152) antibodyFNDC5 Reaktivität: Human WB Wirt: Maus Monoclonal 1736CT532-85-53-92 unconjugated
anti-Fibronectin Type III Domain Containing 5 (FNDC5) (AA 2-137) antibodyFNDC5 Reaktivität: Human WB, IHC, IP, IF/ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Fibronectin Type III Domain Containing 5 (FNDC5) (AA 42-112) antibody (Magnetic Particles)FNDC5 Reaktivität: Human, Maus, Ratte IHC Wirt: Kaninchen Polyclonal Magnetic Particles
-
- Applikationshinweise
- FCM(1:20-100)
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Haltbarkeit
- 12 months
-
-
: "New role of irisin in hepatocytes: The protective effect of hepatic steatosis in vitro." in: Cellular signalling, Vol. 27, Issue 9, pp. 1831-9, (2015) (PubMed).
-
: "New role of irisin in hepatocytes: The protective effect of hepatic steatosis in vitro." in: Cellular signalling, Vol. 27, Issue 9, pp. 1831-9, (2015) (PubMed).
-
- Target
- FNDC5 (Fibronectin Type III Domain Containing 5 (FNDC5))
- Andere Bezeichnung
- FNDC5 (FNDC5 Produkte)
- Synonyme
- FRCP2 antikoerper, irisin antikoerper, 1500001L03Rik antikoerper, AI836596 antikoerper, C87088 antikoerper, PeP antikoerper, Pxp antikoerper, fndc5 antikoerper, si:dkey-264p5.1 antikoerper, zgc:158684 antikoerper, fibronectin type III domain containing 5 antikoerper, fibronectin type III domain containing 5b antikoerper, FNDC5 antikoerper, Fndc5 antikoerper, fndc5b antikoerper
- Hintergrund
-
Synonyms: FRCP2, irisin, Fibronectin type III domain-containing protein 5, Fibronectin type III repeat-containing protein 2, FNDC5
Background: Irisin: Contrary to mouse, may not be involved in the beneficial effects of muscular exercise, nor in the induction of browning of human white adipose tissue.
- Gen-ID
- 252995
- UniProt
- Q8NAU1
- Pathways
- Hormone Activity, Brown Fat Cell Differentiation, Positive Regulation of fat Cell Differentiation
-
